AEON Biopharma, Inc. (NASDAQ:AEON) Expected to Earn FY2028 Earnings of $0.18 Per Share

AEON Biopharma, Inc. (NASDAQ:AEON – Free Report) – Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of AEON Biopharma in a report released on Wednesday, May 15th. HC Wainwright analyst D. Tsao expects that the company will post earnings per share of $0.18 for the year. HC Wainwright currently has a […]

Leave a Reply

Your email address will not be published.

Previous post Syros Pharmaceuticals (NASDAQ:SYRS) Stock Rating Reaffirmed by HC Wainwright
Next post Element Fleet Management (TSE:EFN) Price Target Raised to C$26.00